resveratrol has been researched along with ginsenosides in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weng, J; Xia, X | 1 |
| Baque, MA; Condori, J; Dolan, MC; Grubbs, SK; Lay, JO; Lee, EJ; Medina-Bolivar, F; Paek, KY; Sivakumar, G; Wright, SM | 1 |
| Choi, DK; Koppula, S; Suk, K | 1 |
| Jin, X; Ong, M; Peng, J; Qu, X | 1 |
| Granchi, C; Minutolo, F | 1 |
| Aliev, G; Cacabelos, R; Carrera, I; Fernandez-Novoa, L; Sampedro, C; Tarasov, VV | 1 |
| Naura, AS; Sharma, S | 1 |
| Fan, X; Li, S; Liu, Z; Lu, Y; Ma, Z; Wang, X; Yang, J | 1 |
| Gao, W; Luo, C; Ma, L; Man, S; Yan, M; Zhao, G | 1 |
| Asai, M; Kikegawa, M; Nakajima, A; Sone, H; Uesawa, Y; Yu, J | 1 |
9 review(s) available for resveratrol and ginsenosides
| Article | Year |
|---|---|
Targeting metabolic syndrome: candidate natural agents.
Topics: Animals; Anthocyanins; Berberine; China; Curcumin; Female; Flavanones; Genistein; Ginsenosides; Humans; Male; Medicine, Traditional; Metabolic Syndrome; Mice; Momordica charantia; Phytotherapy; Plant Preparations; Prevalence; Randomized Controlled Trials as Topic; Rats; Resveratrol; Stilbenes | 2010 |
Bioprocess and bioreactor: next generation technology for production of potential plant-based antidiabetic and antioxidant molecules.
Topics: Antioxidants; Arachis; Bioreactors; Biotechnology; Ginsenosides; Hypoglycemic Agents; Plant Roots; Resveratrol; Stilbenes; Triterpenes | 2011 |
Inhibitors of microglial neurotoxicity: focus on natural products.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzyl Alcohols; Biological Products; Biphenyl Compounds; Catechin; Catechols; Curcumin; Encephalitis; Fatty Alcohols; Ginsenosides; Glucosides; Microglia; Molecular Structure; Nerve Degeneration; Neuroprotective Agents; Phenyl Ethers; Plant Extracts; Resveratrol; Stilbenes | 2011 |
Chinese Herbal Medicine for the Optimal Management of Polycystic Ovary Syndrome.
Topics: Androgens; Berberine; Drugs, Chinese Herbal; Female; Ginsenosides; Glucosides; Humans; Insulin Resistance; Monoterpenes; Phenanthrenes; Phytotherapy; Polycystic Ovary Syndrome; Resveratrol; Stilbenes; Theca Cells | 2017 |
Activators of Sirtuin-1 and their Involvement in Cardioprotection.
Topics: Benzimidazoles; Cardiotonic Agents; Cardiovascular Diseases; Cyclooctanes; Ginsenosides; Heterocyclic Compounds, 4 or More Rings; Humans; Lignans; Polycyclic Compounds; Resveratrol; Sirtuin 1 | 2018 |
Dopaminergic Neuroprotection with Atremorine in Parkinson´s Disease.
Topics: Animals; Curcumin; Dopaminergic Neurons; Ginsenosides; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Resveratrol; Vicia faba | 2018 |
Potential of phytochemicals as immune-regulatory compounds in atopic diseases: A review.
Topics: Asthma; Catechols; Curcumin; Dermatitis, Atopic; Fatty Alcohols; Flavonoids; Ginsenosides; Humans; Hypersensitivity; Molecular Structure; Phytochemicals; Resveratrol | 2020 |
Research progress in use of traditional Chinese medicine for treatment of spinal cord injury.
Topics: Curcumin; Ginsenosides; Humans; Medicine, Chinese Traditional; Paclitaxel; Resveratrol; Spinal Cord Injuries | 2020 |
Treatment for liver cancer: From sorafenib to natural products.
Topics: Antineoplastic Agents; Biological Products; Flavonoids; Ginsenosides; Humans; Immediate-Early Proteins; Liver Neoplasms; Neoplastic Stem Cells; Protein Serine-Threonine Kinases; Resveratrol; Sorafenib | 2021 |
1 other study(ies) available for resveratrol and ginsenosides
| Article | Year |
|---|---|
Molecular profiling of ginsenoside metabolites to identify estrogen receptor alpha activity.
Topics: Cell Proliferation; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Gene Expression; Genistein; Ginsenosides; Humans; MCF-7 Cells; Molecular Docking Simulation; Resveratrol; Sapogenins; Signal Transduction; Transcriptome; Triterpenes | 2022 |